MIRA Pharmaceuticals Announced New Insights Garnered From Additional, Recently Received Preclinical Study Data Regarding The Mechanism Of Action And Toxicology Data For Its Oral Ketamine Analog, Ketamir-2
Latest positive preclinical data provides another step in the path to potential IND submission this year for novel ketamine analog.